ドラッグデリバリー技術の世界市場...市場調査レポートについてご紹介

1 Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 27)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 34)

4 Premium Insights (Page No. – 38)
4.1 Market, By Topical Drug Delivery
4.2 Market, By End User
4.3 Solid Oral Drug Delivery Technology Market, By Dosage Form
4.4 Market, By Route of Administration
4.5 Geographic Snapshot of the Market

5 Market Overview (Page No. – 43)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market Segmentation, By Route of Administration
5.2.2 Market Segmentation, By End User
5.2.3 Market Segmentation, By Region
5.3 Market Dynamics
5.4 Drivers
5.4.1 Rising Prevalence of Chronic Diseases
5.4.2 Growth in the Biologics Market
5.4.3 New Product Launches
5.4.4 Drug Innovation and Technological Advancements
5.5 Restraints
5.5.1 Risk of Needle-Stick Injuries and Side Effects Related to Drugs
5.6 Opportunities
5.6.1 Self-Administration and Homecare Drug Delivery
5.6.2 Rising Demand for Biosimilars and Generic Drugs
5.6.2.1 Biosimilars
5.6.2.2 Generic Drugs
5.6.3 Collaborations Among Companies
5.6.4 Focus on Overcoming Unmet Medical Needs
5.6.5 Emerging Markets
5.7 Challenges
5.7.1 Product Recalls
5.7.2 Patent Expiry and Patent Cliff
5.7.3 Regulatory Hurdles and Pricing Pressure

6 Drug Delivery Technology Market, By Route of Administration (Page No. – 58)
6.1 Introduction
6.2 Oral Drug Delivery
6.2.1 Solid Oral Drugs
6.2.1.1 Tablets
6.2.1.2 Capsules
6.2.1.3 Powders
6.2.1.4 Pills
6.2.2 Liquid Oral Drugs
6.2.2.1 Solutions
6.2.2.2 Syrups
6.2.3 Semi-Solid Oral Drugs
6.2.3.1 Gels
6.2.3.2 Emulsions
6.2.3.3 Elixirs
6.3 Pulmonary Drug Delivery
6.3.1 Metered Dose Inhalers
6.3.2 Dry Powder Inhalers
6.3.3 Nebulizers
6.3.3.1 Jet Nebulizers
6.3.3.2 Ultrasonic Nebulizers
6.3.3.3 Soft Mist Nebulizers
6.4 Injectable Drug Delivery
6.4.1 Injectable Drug Delivery Devices
6.4.1.1 Conventional Injectables
6.4.1.2 By Material
6.4.1.2.1 Glass
6.4.1.2.2 Plastic
6.4.1.3 By Product
6.4.1.3.1 Fillable Syringes
6.4.1.3.2 Prefilled Syringes
6.4.1.4 By Usability
6.4.1.4.1 Reusable Syringes
6.4.1.4.2 Disposable Syringes
6.4.1.5 Self-Injection Devices
6.4.1.6 Needle-Free Injectors
6.4.1.7 Autoinjectors
6.4.1.8 Pen Injectors
6.4.1.9 Wearable Injectors
6.4.1.10 Other Devices
6.4.2 Injectable Drug Delivery Formulations
6.4.2.1 Conventional Drug Delivery
6.4.2.2 Novel Drug Delivery Formulations
6.4.2.3 Long-Acting Injection Formulations
6.5 Ocular Drug Delivery
6.5.1 Liquid Ocular Drug Delivery
6.5.1.1 Eye Drops
6.5.1.2 Liquid Sprays
6.5.2 Semi-Solid Ocular Drug Delivery
6.5.2.1 Gels
6.5.2.2 Eye Ointments
6.5.3 Ocular Devices
6.5.3.1 Contact Lenses Coated With Drugs
6.5.3.2 Ocular Inserts
6.6 Nasal Drug Delivery
6.6.1 Nasal Drops
6.6.2 Nasal Sprays
6.6.3 Nasal Powders
6.6.4 Nasal Gels
6.7 Topical Drug Delivery
6.7.1 Liquid Topical Drug Delivery
6.7.1.1 Solutions
6.7.1.2 Suspensions
6.7.2 Semi-Solid Topical Drug Delivery
6.7.2.1 Creams
6.7.2.2 Gels
6.7.2.3 Ointments
6.7.2.4 Pastes
6.7.2.5 Lotions
6.7.3 Solid Topical Drug Delivery
6.7.3.1 Suppositories
6.7.3.2 Powders
6.7.4 Transdermal Drug Delivery
6.7.4.1 Transdermal Patches
6.7.4.2 Transdermal Gels
6.8 Implantable Drug Delivery
6.8.1 Active Implantable Drug Delivery
6.8.2 Passive Implantable Drug Delivery
6.9 Transmucosal Drug Delivery
6.9.1 Oral Transmucosal Drug Delivery
6.9.1.1 Buccal Drug Delivery
6.9.1.2 Sublingual Drug Delivery
6.9.2 Other Transmucosal Drug Delivery
6.9.2.1 Rectal Transmucosal Drug Delivery
6.9.2.2 Vaginal Transmucosal Drug Delivery

7 Drug Delivery Technology Market, By End User (Page No. – 137)
7.1 Introduction
7.2 Hospitals
7.3 Home Care Settings
7.4 Ambulatory Surgical Centers/Clinics
7.5 Diagnostic Centers
7.6 Other End Users

8 Drug Delivery Technology Market, By Region (Page No. – 145)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia
8.5 Rest of the World

9 Competitive Landscape (Page No. – 163)
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situations & Trends
9.3.1 New Product Launches & Approvals
9.3.2 Partnerships, Agreements, and Collaborations
9.3.3 Acquisitions
9.3.4 Expansions

10 Company Profiles (Page No. – 171)
(Overview, Financials, Products & Services, Strategy, & Developments)*
10.1 Introduction
10.2 Bayer AG
10.3 Johnson & Johnson Services, Inc.
10.4 Novartis AG
10.5 Pfizer, Inc.
10.6 F. Hoffmann-La Roche Ltd.
10.7 3M Company
10.8 Antares Pharma, Inc.
10.9 Glaxosmithkline PLC
10.10 Merck & Co., Inc.
10.11 Sanofi

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. – 222)
11.1 Insights From Industry Experts
11.2 Discussion Guide
11.3 Other Developments, 2012–2015
11.4 Available Customizations
11.5 RT: Real-Time Market Intelligence
11.6 Related Reports